# Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms

> **NCT06043011** · — · RECRUITING · sponsor: **iOMEDICO AG** · enrollment: 2950 (estimated)

## Conditions studied

- Chronic Lymphocytic Leukemia (CLL)
- Diffuse Large B-cell Lymphoma (DLBCL)
- Follicular Lymphoma (FL)
- Mantle Cell Lymphoma (MCL)
- Marginal Zone Lymphoma (MZL)
- Waldenström's Macroglobulinemia (WM)

## Interventions

- **OTHER:** Routine care as per site standard.

## Key facts

- **NCT ID:** NCT06043011
- **Lead sponsor:** iOMEDICO AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-27
- **Primary completion:** 2033-12
- **Final completion:** 2033-12
- **Target enrollment:** 2950 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06043011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06043011, "Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06043011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*